mechanisms underlying the efficacy of antibodies generated by a vaccine

omniscientis

omniscientis

SARS-CoV-2 Antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance

 

Background: Antibody response period following SARS-CoV-2 an infection tends to be variable and relies on severity of illness and methodology of detection.

Research design and strategies: COVID-19 convalescent plasma (CCP) from 18 donors was collected longitudinally for a most of 63 – 129 days following decision of signs. All of the samples have been initially screened by the Ortho Complete Ig check to substantiate positivity and subsequently examined with 7 extra direct sandwich or oblique binding assays (Ortho, Roche, Abbott, Broad Institute) directed towards quite a lot of antigen targets (S1, RBD, and NC), together with 2 neutralization assays (Broad Institute stay virus PRNT and Vitalant Analysis Institute Pseudovirus RVPN).

Outcomes: The direct detection assays (Ortho Complete Ig complete and Roche Complete Ig) confirmed rising ranges of antibodies over the time interval, in distinction to the oblique IgG assays that confirmed a decline. Neutralization assays additionally demonstrated declining responses; the VRI RVPN pseudovirus had a higher fee of decline than the Broad PRNT stay virus assay.

Dialogue: These information present that along with variable particular person responses and associations with illness severity, the detection assay chosen contributes to the heterogeneous ends in antibody stability over time. Relying on the scope of the analysis, one assay could also be preferable over one other. For serosurveillance research, direct, double Ag-sandwich assays look like your best option as a consequence of their stability; specifically, algorithms that embrace each S1 and NC primarily based assays might help cut back the speed of false-positivity and discriminate between pure an infection and vaccine-derived seroreactivity.

 

Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to deal with oxycodone use dysfunction

 

Therapeutic vaccines supply a viable technique to deal with opioid use issues (OUD) complementary to present pharmacotherapies. The candidate Oxy(Gly)4-sKLH vaccine focusing on oxycodone displayed pre-clinical proof of efficacy, selectivity and security, and it’s now present process medical analysis. To additional help its implementation within the clinic, this research examined important in vivo neuropsychopharmacological properties of the Oxy(Gly)4-sKLH vaccine in rats. Whereas repeated immunizations with Oxy(Gly)4-sKLH have been essential to take care of the antibody response time beyond regulation, publicity to free oxycodone didn’t enhance oxycodone-specific antibody ranges in vaccinated rats, limiting issues of immune-related unwanted side effects. Immunization with Oxy(Gly)4-sKLH achieved sustained antibody titers over a interval of 5 months following preliminary vaccination, supporting its potential for offering long-lasting safety.

In vivo research of selectivity confirmed that vaccination prevented oxycodone-induced however not methadone-induced antinociception, whereas nonetheless preserving the opioid antagonist naloxone’s pharmacological results. Vaccination didn’t intrude with fentanyl-induced antinociception or fentanyl distribution to the mind. These in vivo information verify the beforehand reported in vitro selectivity profile of Oxy(Gly)4-sKLH. Vaccination prolonged oxycodone’s half-life as much as 25 hr in comparison with management. Whereas vaccination lowered the reinforcing efficacy of oxycodone in an intravenous self-administration mannequin, indicators of toxicity weren’t noticed. These rodent research verify that energetic immunization with Oxy(Gly)4-sKLH induces extremely particular and long-lasting antibodies that are efficient in lowering the reinforcing results of oxycodone whereas preserving the efficacy of medicines used to deal with OUD and overdose.

omniscientis
omniscientis

Anti-Galectin-3 Monoclonal Antibody

M00621-1 100ul
EUR 397
Description: Mouse Monoclonal Galectin-3 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

anti-Galectin 1

YF-PA12945 100 ug
EUR 403
Description: Rabbit polyclonal to Galectin 1

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

Anti-Galectin 1 Antibody

A00470-2 100ug/vial
EUR 294

anti- Galectin-1 antibody

FNab03314 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500-1:1000
  • IHC: 1:20-1:200
  • Immunogen: lectin, galactoside-binding, soluble, 1
  • Uniprot ID: P09382
  • Gene ID: 3956
  • Research Area: Cell Division and Proliferation, Cardiovascular, Signal Transduction
Description: Antibody raised against Galectin-1

anti- Galectin-1 antibody

FNab03315 100µg
EUR 548.75
  • Recommended dilution: WB: 1:500-1:2000
  • IHC: 1:20-1:200
  • Immunogen: lectin, galactoside-binding, soluble, 1
  • Uniprot ID: P09382
  • Gene ID: 3956
  • Research Area: Cell Division and Proliferation, Cardiovascular, Signal Transduction
Description: Antibody raised against Galectin-1

Anti-Galectin-1 antibody

PAab03314 100 ug
EUR 355

Anti-Galectin-1 antibody

STJ93201 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

Anti-Galectin-1 antibody

STJ98716 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

Anti-Galectin 1 (1A8)

YF-MA13984 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin 1/Lgals1 Antibody

A00470 100ug/vial
EUR 334

Anti-Galectin 1 Biotinylated Antibody

A00470-Biotin 50ug/vial
EUR 294

Anti-Galectin 1/LGALS1 Antibody

PA1422 100ug/vial
EUR 334

anti-Galectin 1 (1E8-1B2)

LF-MA10174 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin 1/LGALS1 Antibody

PB9240 100ug/vial
EUR 334

Anti-galectin-1 (mouse) antibody

STJ72519 100 µg
EUR 359

Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody

M08143-1 100ug/vial
EUR 397
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human.

anti-Galectin 3

YF-PA12946 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 3

anti-Galectin 3

YF-PA12947 100 ul
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 3

YF-PA12948 100 ug
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 8

YF-PA12951 50 ul
EUR 363
Description: Mouse polyclonal to Galectin 8

anti-Galectin 13

YF-PA18585 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 13

anti-Galectin 3

YF-PA24079 50 ul
EUR 334
Description: Mouse polyclonal to Galectin 3

anti-galectin 9

YF-PA24081 50 ul
EUR 334
Description: Mouse polyclonal to galectin 9

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag

PROTP47929-1 Regular: 20ug
EUR 317
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques.

LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag

PROTO00214-1 Regular: 10ug
EUR 317
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag

PROTP17931-1 Regular: 25ug
EUR 317
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_

Anti-human Galectin-3 antibody

STJ15100163 250 µg
EUR 336
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

Human Galectin-3 (Gal-3) AssayMax ELISA Kit

EG3311-1 96 Well Plate
EUR 477

Human Galectin-4 (Gal-4) AssayMax ELISA Kit

EG3312-1 96 Well Plate
EUR 477

Recombinant Human Galectin-1

7-00427 10µg Ask for price

Recombinant Human Galectin-1

7-00428 50µg Ask for price

Recombinant Human Galectin-1

7-00429 1mg Ask for price

Galectin-1, human recombinant

4648-10
EUR 142

Galectin-1, human recombinant

4648-1000
EUR 1648

Galectin-1, human recombinant

4648-50
EUR 262

Human Galectin-1 (LGALS1)

1-CSB-EP012882HU
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
  • MW: 30.6 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)

1-CSB-EP012882HUb1
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
  • MW: 19.6 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin 1 Protein

20-abx066725
  • EUR 620.00
  • EUR 272.00
  • EUR 1859.00
  • EUR 732.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Anti-Galectin-9 Antibody

A03415 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Galectin-9 Antibody (LGALS9) detection.tested for WB in Human, Mouse, Rat.

anti- Galectin 2 antibody

FNab03310 100µg
EUR 585
  • Immunogen: lectin, galactoside-binding, soluble, 2
  • Uniprot ID: P05162
  • Research Area: Immunology, Signal Transduction, Cell Division and Proliferation
Description: Antibody raised against Galectin 2

anti- Galectin 4 antibody

FNab03311 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500-1:1000
  • IHC: 1:20-1:200
  • IF: 1:10-1:100
  • Immunogen: lectin, galactoside-binding, soluble, 4
  • Uniprot ID: P56470
  • Research Area: Immunology, Signal Transduction, Cell Division and Proliferation
Description: Antibody raised against Galectin 4

anti- Galectin 8 antibody

FNab03312 100µg
EUR 505.25
  • Immunogen: lectin, galactoside-binding, soluble, 8
  • Uniprot ID: O00214
  • Research Area: Immunology, Signal Transduction, Cell Division and Proliferation
Description: Antibody raised against Galectin 8

anti- Galectin 9 antibody

FNab03313 100µg
EUR 505.25
  • Immunogen: lectin, galactoside-binding, soluble, 9
  • Uniprot ID: O00182
  • Research Area: Immunology, Signal Transduction, Cell Division and Proliferation
Description: Antibody raised against Galectin 9

anti- Galectin-3 antibody

FNab03316 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500-1:5000
  • IP: 1:200-1:2000
  • IHC: 1:20-1:200
  • IF: 1:10-1:100
  • Immunogen: lectin, galactoside-binding, soluble, 3
  • Uniprot ID: P17931
  • Research Area: Cardiovascular, Cancer, Immunology, Neuroscience, Cell Division and Prolife
  • Show more
Description: Antibody raised against Galectin-3

anti- Galectin-3 antibody

FNab03317 100µg
EUR 548.75
  • Recommended dilution: WB: 1:1000-1:5000
  • IHC: 1:50-1:200
  • IF: 1:20-1:200
  • Immunogen: lectin, galactoside-binding, soluble, 3
  • Uniprot ID: P17931
  • Research Area: Cardiovascular, Cancer, Immunology, Neuroscience, Cell Division and Proliferation
Description: Antibody raised against Galectin-3

anti- Galectin-7 antibody

FNab03318 100µg
EUR 505.25
  • Recommended dilution: WB: 1:1000-1:4000
  • IHC: 1:20-1:200
  • Immunogen: lectin, galactoside-binding, soluble, 7B
  • Uniprot ID: P47929
  • Gene ID: 653499
  • Research Area: Immunology, Cancer, Immunology, Neuroscience, Cell Division and Proliferation
Description: Antibody raised against Galectin-7

anti-Galectin-3 (6G2)

LF-MA20336 100 ug
EUR 354
Description: Mouse monoclonal to Galectin-3

Anti-Galectin 2 antibody

PAab03310 100 ug
EUR 412

Anti-Galectin 4 antibody

PAab03311 100 ug
EUR 355

Anti-Galectin 8 antibody

PAab03312 100 ug
EUR 355

Anti-Galectin 9 antibody

PAab03313 100 ug
EUR 355

Anti-Galectin-3 antibody

PAab03316 100 ug
EUR 355

Anti-Galectin-7 antibody

PAab03318 100 ug
EUR 355

Anti-Galectin-3 antibody

STJ16100369 1 mL
EUR 1047

Anti-Galectin-3 antibody

STJ16100782 100 µg
EUR 720

Anti-Galectin-2 antibody

STJ93202 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-2.

Anti-Galectin-4 antibody

STJ93203 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-4.

Anti-Galectin-7 antibody

STJ93204 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-7.

Anti-Galectin-8 antibody

STJ93205 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-8.

Anti-Galectin-9 antibody

STJ93206 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-9.

Anti-Galectin 3 antibody

STJ73098 100 µg
EUR 359

Anti-Galectin-3 antibody

STJ180106 0.1 ml
EUR 212

Anti-Galectin 3 antibody

STJ190057 200 µl
EUR 197
Description: Unconjugated Mouse monoclonal to Galectin 3 (AS1A24)

Anti-Galectin-3 antibody

STJ96945 200 µl
EUR 197
Description: Galectin-3 is a protein encoded by the LGALS3 gene which is approximately 26,1 kDa. Galectin-3 is localised to the cytoplasm and nucleus. It is involved in NF-kappaB signalling, advanced glycosylation end product receptor signalling and cell adhesion. It is a galactose-specific lectin which binds IgE and may mediate the stimulation by CSPG4 of endothelial cells migration along with the alpha-3, beta-1 integrin. It is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. Galectin-3 is expressed mainly in the colonic epithelium and is also abundantly expressed in activated macrophages. Mutations in the LGALS3 gene may result in follicular adenoma and thyroid cancer. STJ96945 was developed from clone 6G2 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. This antibody detects endogenous galectin-3 proteins.

Anti-Galectin-3 antibody

STJ97549 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (6B8).

Anti-Galectin-3 antibody

STJ97550 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (8D7).

Anti-Galectin-3 antibody

STJ97551 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (5D9).

Anti-Galectin-3 antibody

STJ97601 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (2F9).

Anti-Galectin-3 antibody

STJ97604 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (16E6).

Anti-Galectin-3 antibody

STJ97605 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (1H4).

Anti-Galectin-3 antibody

STJ97715 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3.

Anti-Galectin 8 (3E5)

YF-MA13986 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 8

Anti-galectin-1 (mouse) (aa100-112) antibody

STJ72520 100 µg
EUR 359

Anti Human Galectin-3 Polyclonal Antibody

KH040
EUR 649
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur.

Anti-Galectin-1 / Human Placental Lactogen (hPL) Monoclonal Antibody

M00470 100ug/vial
EUR 397
Description: Mouse Monoclonal Galectin-1 / Human Placental Lactogen (hPL) Antibody. Validated in IHC and tested in Human.

Galectin 1 protein

30R-1385 100 ug
EUR 224
Description: Purified recombinant Human Galectin 1 protein

Galectin 1 protein

30R-2371 50 ug
EUR 353
Description: Purified recombinant Human Galectin 1 protein

Galectin 1 protein

30R-AG003 10 ug
EUR 133
Description: Purified recombinant Human Galectin 1 protein

Galectin 1 antibody

70R-11939 100 ug
EUR 403
Description: Rabbit polyclonal Galectin 1 antibody

Galectin 1 antibody

70R-13963 100 ug
EUR 322
Description: Affinity purified Rabbit polyclonal Galectin 1 antibody

Galectin-1 Antibody

3596-100
EUR 316

Galectin-1 Antibody

3596-30T
EUR 146

Galectin 1 Antibody

49673-100ul 100ul
EUR 333

Galectin 1 Antibody

49673-50ul 50ul
EUR 239

Galectin 1 antibody

70R-GR002 100 ug
EUR 476
Description: Affinity purified Rabbit polyclonal Galectin 1 antibody

Galectin 1 antibody

70R-49997 100 ul
EUR 244
Description: Purified Polyclonal Galectin 1 antibody

Galectin-1 Protein

20-abx261634
  • EUR 3418.00
  • EUR 328.00
  • EUR 230.00
  • 1 mg
  • 20 ug
  • 5 ug
  • Shipped within 5-10 working days.

Galectin-1 Protein

20-abx263505
  • EUR 230.00
  • EUR 1790.00
  • EUR 328.00
  • 10 ug
  • 1 mg
  • 50 ug
  • Shipped within 5-10 working days.

rHu Galectin-1

AK8281-0010 10µg Ask for price

rHu Galectin-1

AK8281-0050 50µg Ask for price

rHu Galectin-1

AK8281-0100 100µg Ask for price

rHu Galectin-1

AK8281-1000 1mg Ask for price

Galectin-1 (LGAS1)

PR27143 50 ug
EUR 318

Human Galectin-1 (Gal-1) Antibody

30005-05111 150 ug
EUR 261

Human Galectin 1 ELISA kit

E01G0038-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit

E01G0038-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit

E01G0038-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1 (LGALS1) Protein

abx670211-50ug 50 ug
EUR 551
  • Shipped within 1 week.

Recombinant Human Galectin-1 Protein

RP00007 20 μg
EUR 174

Anti-Apaf-1 (human) Monoclonal Antibody (2E12)

M00889-1 100ug
EUR 432
Description: Rat Monoclonal Apaf-1 (human) Antibody (2E12). Validated in ELISA, IP, IF, WB and tested in Human.

Anti-Galectin 10/CLC Antibody

A01350 100ug/vial
EUR 294

Anti-Galectin 3/LGALS3 Antibody

PB9081 100ug/vial
EUR 334

Anti-Galectin 3/LGALS3 Antibody

PB9279 100ug/vial
EUR 334

Anti-Galectin 8/LGALS8 Antibody

PB9659 100ug/vial
EUR 294

Anti-galectin 9/LGALS9 Antibody

PB9660 100ug/vial
EUR 294

Anti-Galectin-3 10301 antibody

STJ400238 1 mg
EUR 446

Anti-Galectin-3 10302 antibody

STJ400239 1 mg
EUR 446

Anti-Galectin-3 10303 antibody

STJ400240 1 mg
EUR 446

Anti-Galectin-3 10304 antibody

STJ400241 1 mg
EUR 446

Anti-Galectin-3 10305 antibody

STJ400242 1 mg
EUR 446

Anti-galectin-3 (mouse) antibody

STJ72518 100 µg
EUR 359

Anti-Periphilin 1 Antibody

A06996-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Periphilin 1 Antibody (PPHLN1) detection.tested for WB in Human, Mouse.

Anti-Lyl-1 Antibody

A07491-1 100ul
EUR 397
Description: Rabbit Polyclonal Lyl-1 Antibody. Validated in IHC and tested in Human, Mouse, Rat.

Anti-GLI-1 Antibody

A07972-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for GLI-1 Antibody (ACSS1) detection. Tested with WB in Human, Mouse, Rat.

Anti-Cerebellin 1 Antibody

A09176-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Cerebellin 1 Antibody (CBLN1) detection. Tested with WB in Human, Mouse, Rat.

Anti-DOC-1 Antibody

A09467-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for DOC-1 Antibody (CDK2AP1) detection. Tested with WB in Human, Mouse.

Anti-NPDC-1 Antibody

A12846-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for NPDC-1 Antibody (NPDC1) detection. Tested with WB in Human, Mouse, Rat.

Anti-CNG-1 Antibody

A05494-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for CNG-1 Antibody (CNGA1) detection. Tested with WB in Human, Mouse, Rat.

Anti-Flk-1 Antibody

A00901-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Flk-1 Antibody (KDR) detection.tested for WB in Human, Mouse.

Anti-EDG-1 Antibody

A01502-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for EDG-1 Antibody (S1PR1) detection.tested for WB in Human, Mouse, Rat.

Anti-ROBO-1 Antibody

A01530-1 100ug
EUR 455
Description: Rabbit Polyclonal ROBO-1 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

Anti-Bag-1 Antibody

A02423-1 50 ul
EUR 397
Description: Rabbit Polyclonal Bag-1 Antibody. Validated in IP, IHC and tested in Bovine, Canine, Human, Mouse, Rat.

Anti-TUB 1 Antibody

A02917-1 100ug/vial
EUR 294

Anti-Dok-1 Antibody

A03039-1 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Dok-1 Antibody (DOK1) detection.tested for WB in Human, Mouse, Rat.

Myelin Oligodendrocyte Glycoprotein-antibody-associated Dysfunction Presenting with Corticomeningeal Encephalitis previous to the Onset of Optic Neuritis

 

We herein report a case of myelin oligodendrocyte glycoprotein-antibody-associated dysfunction (MOG-AD) presenting with corticomeningeal encephalitis. The affected person exhibited oral ulceration, a light impairment of consciousness, fever, nausea, nuchal rigidity, positivity for human leukocyte antigen kind B51, and neutrophil-dominant pleocytosis and interleukin-6 stage in cerebrospinal fluid (CSF). Magnetic resonance imaging (MRI) revealed a proper temporal lesion with leptomeningeal gadolinium enhancement.

The preliminary analysis was neuro-Behçet’s illness presenting with meningoencephalitis; nevertheless, a cell-based assay detected anti-MOG antibody within the serum and CSF and the affected person additionally skilled bilateral optic neuritis. After administering steroid remedy, his neurologic signs and CSF abnormalities improved together with the disappearance of gadolinium enhancement and the lesion on MRI. This case means that MOG-AD might current with corticomeningeal encephalitis previous to the onset of optic neuritis.

Excessive antibody ranges towards human herpesvirus-6A work together with life-style components in a number of sclerosis growth

 

Background: An infection with human herpesvirus 6A (HHV-6A) has been prompt to extend a number of sclerosis (MS) danger. Nonetheless, potential interactions between HHV-6A and environmental/life-style danger components for MS haven’t beforehand been studied.

Strategies: We used two Swedish population-based case-control research comprising 5993 instances and 5995 controls. Utilizing logistic regression fashions, topics with totally different HHV-6A antibody ranges, environmental exposures, and life-style habits have been in contrast relating to MS danger, by calculating odds ratios (ORs) with 95% confidence intervals (CIs). Potential interactions between excessive HHV-6A antibody ranges and customary environmental exposures and life-style components have been evaluated on the additive scale.

Outcomes: Excessive HHV-6A antibody ranges have been related to elevated danger of creating MS (OR = 1.5, 95% CI = 1.4-1.6). Concerning MS danger, vital interactions have been noticed between excessive HHV-6A antibody ranges and each smoking (attributable proportion (AP) = 0.2, 95% CI = 0.1-0.3), low ultraviolet radiation (UVR) publicity (AP = 0.3, 95% CI = 0.1-0.4), and low vitamin D ranges (AP = 0.3, 95% CI = 0.0-0.6).

Conclusion: Excessive HHV-6A antibody ranges are related to elevated MS danger and act synergistically with widespread environmental/life-style danger components for MS. Additional analysis is required to research potential mechanisms underlying the interactions introduced on this research.

Immune subtraction for improved decision in serum protein immunofixation electrophoresis and antibody isotype willpower in a affected person with autoantibody

Heavy chain isotypes of low stage monoclonal immunoglobulins are typically obscured in serum immunofixation electrophoresis (SIFE) by a heavy background of polyclonal immunoglobulins. Nonetheless, correct willpower of the heavy chain isotype is important for a whole analysis, as isotype willpower of autoantibodies might have relevance in figuring out therapeutic procedures. Immune subtraction (IS) was employed in a affected person with neuropathy and GD1a autoantibody. IS allowed identification of the cognate heavy chain associated to a lambda gentle chain restriction famous on preliminary SIFE in addition to isotype willpower of the autoantibody. Antisera particular to particular person heavy and light-weight chains have been used for depletion of particular immunoglobulin sorts. Depletion of kappa gentle chain related immunoglobulins allowed unequivocal willpower of the isotype of lambda gentle chain-associated low stage monoclonal band to be IgG Lambda. Selective depletion of kappa, lambda, gamma and mu heavy chain immunoglobulins was employed to decide IgG Kappa isotype of the auto-antibody.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *